BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36593459)

  • 21. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
    Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINE-1 Methylation Patterns as a Predictor of Postmolar Gestational Trophoblastic Neoplasia.
    Lertkhachonsuk R; Paiwattananupant K; Tantbirojn P; Rattanatanyong P; Mutirangura A
    Biomed Res Int; 2015; 2015():421747. PubMed ID: 26448937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.
    Braga A; Canelas AC; Torres B; Maesta I; Giongo Pedrotti L; Bessel M; Vieira Dos Santos Esteves AP; Amim Junior J; Rezende Filho J; Elias KM; Horowitz NS; Berkowitz RS
    PLoS One; 2022; 17(12):e0277892. PubMed ID: 36454778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report.
    Mu X; Yin R; Wang D; Song L; Ma Y; Zhao X; Li Q
    Medicine (Baltimore); 2018 Sep; 97(38):e12424. PubMed ID: 30235719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia.
    Ramírez LAC; Maestá I; Bianconi MI; Jankilevich G; Otero S; Mejía CRV; Cortés-Charry R; Elias KM; Horowitz NS; Seckl M; Berkowitz RS
    Rev Bras Ginecol Obstet; 2022 Aug; 44(8):746-754. PubMed ID: 35760362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Berkowitz RS; Goldstein DP; Bernstein MR; Ramírez LA; Horowitz NS
    Gynecol Oncol; 2015 Jul; 138(1):50-4. PubMed ID: 25933681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
    Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive.
    Bolze PA; Mathe M; Hajri T; You B; Dabi Y; Schott AM; Patrier S; Massardier J; Golfier F
    Gynecol Oncol; 2018 Aug; 150(2):282-287. PubMed ID: 29887485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
    Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R
    Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789
    [No Abstract]   [Full Text] [Related]  

  • 39. Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
    Hemida R; Vos EL; El-Deek B; Arafa M; Toson E; Burger CW; van Doorn HC
    Obstet Gynecol; 2019 May; 133(5):1024-1031. PubMed ID: 30969220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
    Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.